Mibavademab is a hinge-stabilized human IgG4 monoclonal antibody targeting the leptin receptor (LEPR), produced in CHO cells. It is utilized in research for congenital leptin deficiency, with applications in both in vitro binding assays and in vivo metabolic studies.
Concentration:
9.628 mg/mL
Molecular Weight:
~150 kDa
Purity:
98.99% (May vary between batches)
CAS Number:
[2305770-44-7]
Target:
Neuropeptide Y Receptor
* VAT and and shipping costs not included. Errors and price changes excepted